Failure of cell-mediated immunity allows reactivation of the ‘JC’ polyomavirus (JCV) in oligodendrocytes, and the development of progressive multifocal leukoencephalopathy (PML). This is most commonly associated with advanced human immunodeficiency virus (HIV) infection, but is also described after biological therapies such as natalizumab, and rarely other conditions.
This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.
